Ken has more than 30 years of experience in corporate finance. He served as the Chairman and Chief Executive Officer of The Goldman Sachs Group, Inc. in Asia Pacific Ex-Japan before his retirement in 2019. He was also a member of Goldman Sachs’ Management Committee and co-chaired its Asia Pacific Management Committee. Ken currently serves as Chairman of Cydar Medical and of Sphere Fluidics. He is a Board Member of both Wuxi Biologics and CStone Pharmaceuticals. He serves as the senior advisor to WuxiApptec. Previously, Ken served as President of Goldman Sachs in Asia Pacific Ex-Japan from 2013 to 2017. Prior to relocating to Hong Kong, he was global head of Goldman Sachs’ Healthcare Banking Group and global co-head of its Technology, Media and Telecom Group. He was named managing director in 2000 and partner in 2002. He became head of the global medical device banking practice in 1998 and head of the global pharmaceutical banking practice in 2001. He began his career with Goldman Sachs’ Corporate Finance Department in 1992. Prior to joining the firm, Ken was a lieutenant commander and naval aviator in the US Navy. Ken is an adjunct professor at Columbia Business School, a member of the Board of Wuxi Biologics, and a member of the BioFrontiers Institute Advisory Board at the University of Colorado. He also serves on the board of the Faculty of Business and Economics at The University of Hong Kong, and the Asia Pacific Council of The Nature Conservancy. Ken earned a BA from the University of Colorado in 1982 and an MBA as a merit fellow from Columbia University Business School in 1992.